Multiomics Analysis across the Life Cycle Identifies Zn2Cys6_61 as a Target for Enhancing Triterpenoid Production in Ganoderma lucidum.

Metadata-grounded summary

Citation abstract

Ganoderic acids (GAs) are high-value lanostane-type triterpenoids derived from Ganoderma lucidum ( G. lucidum ) with broad applications in functional foods and nutraceuticals, yet their low natural abundance limits industrial production. In this study, an integrated life-cycle multiomics analysis combining metabolomics, transcriptomics, and proteomics was conducted across six developmental stages in four G. lucidum strains to elucidate regulatory mechanisms governing GA biosynthesis. Weighted gene coexpression network analysis identified candidate cytochrome P450 enzymes and transcription factors associated with GA accumulation. A Zn 2 Cys 6 -type transcription factor, Zn 2 Cys 6 _61, was identified as a central regulator and functionally validated through overexpression and RNA interference. Genetic manipulation of Zn 2 Cys 6 _61 expression significantly altered GA levels, with overexpression markedly enhancing GA accumulation. Further analysis demonstrated that Zn 2 Cys 6 _61 directly binds to and activates the promoter of squalene synthase, a key enzyme in triterpenoid backbone biosynthesis. Together, these findings identify Zn 2 Cys 6 _61 as an effective engineering target and provide a transcription factor-based strategy for improving GA production in medicinal mushrooms.